PharmaSUG2025paper·China·Data Standards and Submission (DS)
ISI in Biopharmaceutical Development: Structure, Challenges, and Experience DS-129 Shanghai
Official-source directory
Conference Papers
13,885
available papers
10
available conferences
Papers
Showing 1821–1840 of 13,885
PharmaSUG2025paper·China·Data Standards and Submission (DS)
From Data to Regulatory: Best Statistical Programming Practices for Population PK, Concentration-QTc and Exposure-Response Analyses DS-133 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Implementing CDISC SDTMIG v3.4: Practical Strategies and Lessons from Real-World Programming DS-134 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Leveraging the Company's Submission Library of Data Reviewer's Guides to Accelerate Data Validation with Pinnacle 21 DS-139 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Strategic Statistical Programming for ADR Table Generation in Regulatory Submissions and Corporate Applications DS-142 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Optimizing ISS Analysis for Multi-Indication Submissions DS-146 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Bridging the Gap: How to Prepare Analysis and Electronic Submission for Companion Diagnostics (CDx) Bridging Studies in China DS-163 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Streamlining Clinical Data Translation from Chinese to English: Ensuring Confidentiality and Efficiency in Pharmaceutical Partnerships DS-166 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Re-designing SDTM Automation: Maximizing CDASH Process Values and Understanding Code-Specs Relationship DS-167 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Navigating Unit Standardization in Clinical Trials: Bridging FDA and SI Unit Requirements through LB and LC Domains DS-175 Shanghai
PharmaSUG2025paper·China·Data Standards and Submission (DS)
Immunogenicity Analysis Data Model (ADIS) Design Strategy by Using Categorical Analysis Variables DS-176 Shanghai
PharmaSUG2025paper·US·Data Visualization and Reporting
Visually Exploring Kaplan-Meier Curves Using SAS GTL and R survminer DV-018
PharmaSUG2025paper·US·Data Visualization and Reporting
Jazz Up Your Profile: Perfect Patient Profiles in SAS® using ODS Statistical Graphics DV-029
PharmaSUG2025paper·US·Data Visualization and Reporting
A Case Study on Visualization Methods in R DV-034
PharmaSUG2025paper·US·Data Visualization and Reporting
Visualizing oncology data through 3D bar charts in R and Python DV-071
PharmaSUG2025paper·US·Data Visualization and Reporting
Risk Mitigation Solution for Kaplan-Meier Plot in Drug Labeling DV-148
PharmaSUG2025paper·US·Data Visualization and Reporting
Amazing Graph Series: Advanced SAS® Visualization to Wake Up Your Data – From Static to Fantastic DV-150
PharmaSUG2025paper·US·Data Visualization and Reporting
Efficiently Creating Multiple Graphs on One Page utilizing SAS: Comparing PROC GREPLAY and ODS LAYOUT Approaches DV-158
PharmaSUG2025paper·US·Data Visualization and Reporting
An Integrated R Shiny Solution for Dynamic Subgroup Adjustments and Customizations DV-160
PharmaSUG2025paper·US·Data Visualization and Reporting
Beyond Basic SG Procedures: Enhancing Visualizations in SAS Graphic DV-188